• This email address is being protected from spambots. You need JavaScript enabled to view it.
  • Sun - Fri 8:00 - 20:30

Novaliq’s NovaTears® Treatment for Evaporative Dry Eye Disease is Now Available across Australia and New Zealand

Novaliq GmbH, a specialty pharmaceutical company with the first water-free technology platform that transforms poorly soluble drugs into effective therapeutics for ophthalmology, announced that NovaTears®, a novel topical treatment of dry eye disease (DED) and meibomian gland dysfunction (MGD), is now also available in Australia.

Read more →
Synaptive Medical's Modus V™, a digital robotic microscope

World Renowned Academic Medical Center Acquires Synaptive's Next-Generation Robotic System for Minimally Invasive Neurosurgery

Synaptive Medical Inc., a Toronto-based medical technology company, today announced that Duke University Medical Center has acquired its connected neurosurgery system. Modus V™, the cornerstone of the company’s automated robotic and imaging technology, sets the new standard for visual accuracy during surgery and advances minimally invasive cranial and spine procedures.

Read more →